{{Rsnum
|rsid=17560407
|Gene=MEF2C
|Chromosome=5
|position=88887834
|Orientation=plus
|GMAF=0.1722
|Gene_s=MEF2C
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 59.8 | 37.5 | 2.7
| HCB | 56.2 | 37.2 | 6.6
| JPT | 49.6 | 39.8 | 10.6
| YRI | 92.5 | 7.5 | 0.0
| ASW | 86.0 | 14.0 | 0.0
| CHB | 56.2 | 37.2 | 6.6
| CHD | 59.6 | 33.0 | 7.3
| GIH | 58.4 | 40.6 | 1.0
| LWK | 83.6 | 13.6 | 2.7
| MEX | 74.1 | 25.9 | 0.0
| MKK | 82.7 | 17.3 | 0.0
| TSI | 52.0 | 41.2 | 6.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=G
  |Pval=5E-7
  |OR=23.23
  |ORtxt=[14.14-32.32] mg/dL decrease
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}